Safety and efficacy of filgotinib: Up to 4-year results from an open-label extension study of phase II rheumatoid arthritis programs

Arthur Kavanaugh, Rene R. Westhovens, Kevin L. Winthrop, Susan J. Lee, Ying Meei Tan, Di An, Lei Ye, John S. Sundy, Robin Besuyen, Luc Meuleners, Mykola Stanislavchuk, Alberto J. Spindler, Maria Greenwald, Rieke Alten, Mark C. Genovese

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of filgotinib: Up to 4-year results from an open-label extension study of phase II rheumatoid arthritis programs'. Together they form a unique fingerprint.

Medicine & Life Sciences